71 A. J. Stull et al., “Bioactives in blueberries improve insulin sensitivity in obese, insulin-resistant men and women.” Journal of Nutrition 140, no. 10 (October 2010): 1764–68.
72 R. A. Whitmer et al., “Central obesity and increased risk of dementia more than three decades later.” Neurology 71, no. 14 (September 2008): 1057–64.
73 M. Ashwell et al., “Waist-to-height ratio is more predictive of years of life lost than body mass index.” PloS One 9, no. 9 (January 2014): e103483.
74 L. C. Aiello et al., “Energetic consequences of being a Homo erectus female.” American Journal of Human Biology: The Official Journal of the Human Biology Council 14, no. 5 (January): 551–65.
75 J. M. Seddon et al., “Cigarette smoking, fish consumption, omega-3 fatty acid intake, and associations with age-related macular degeneration: the US Twin Study of Age-Related Macular Degeneration.” Archives of Ophthalmology 124, no. 7 (July 2006): 995–1001.
76 J. P. SanGiovanni et al., “The relationship of dietary lipid intake and age-related macular degeneration in a case-control study: AREDS Report No. 20.” Archives of Ophthalmology 125, no. 5 (May 2007): 671–79.
77 K. M. Connor et al., “Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis.” Nature Medicine 13, no. 7 (July 2007): 868–73.
78 E. Cho et al., “Prospective study of dietary fat and the risk of age-related macular degeneration.” American Journal of Clinical Nutrition 73, no. 2 (February 2001): 209–18.
79 D. Di Giuseppe et al., “Long-term intake of dietary long-chain n-3 polyunsaturated fatty acids and risk of rheumatoid arthritis: a prospective cohort study of women.” Annals of the Rheumatic Diseases (August 2013).
8 °C. Raji et al., “Regular fish consumption is associated with larger gray matter volumes and reduced risk for cognitive decline in the cardiovascular health study.” Доклад на конференции, декабрь 2011.
81 B. M. van Gelder et al., “Fish consumption, n-3 fatty acids, and subsequent 5-y cognitive decline in elderly men: the Zutphen Elderly Study.” American Journal of Clinical Nutrition 85, no. 4 (April 2007): 1142–47.
82 A. Chauhan et al., “Walnuts-rich diet improves memory deficits and learning skills in transgenic mouse model of Alzheimer’s disease.” Alzheimer’s and Dementia 6, no. 4 (July 2010): S69.
83 B. Muthaiyah et al., “Dietary supplementation of walnuts improves memory deficits and learning skills in transgenic mouse model of Alzheimer’s disease.” Journal of Alzheimer’s Disease 42, no. 4 (January 2014): 1397–405.
84 J. O’Brien et al., “Long-term intake of nuts in relation to cognitive function in older women.” Journal of Nutrition, Health and Aging 18, no. 5 (May 2014): 496–502.
85 P. Pribis et al., “Effects of walnut consumption on cognitive performance in young adults.” British Journal of Nutrition 107, no. 9 (May 2012): 1393–401.
86 F. B. Hu et al., “Nut consumption and risk of coronary heart disease: a review of epidemiologic evidence.” Current Atherosclerosis Reports 1, no. 3 (November 1999): 204–9.
87 A. Leaf, “Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils.” Circulation 107, no. 21 (June 2003): 2646–52.
88 H. Cao et al., “Omega-3 fatty acids in the prevention of atrial fibrillation recurrences after cardioversion: a meta-analysis of randomized controlled trials.” Internal Medicine 51, no. 18 (January 2012): 2503–8.
89 H. Aarsetøy et al., “Low levels of cellular omega-3 increase the risk of ventricular fibrillation during the acute ischaemic phase of a myocardial infarction.” Resuscitation 78, no. 3 (September 2008): 258–64.
90 R. Marchioli et al., “Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione.” Circulation 105, no. 16 (April 2002): 1897–903.
91 C. M. Albert et al., “Blood levels of long-chain n-3 fatty acids and the risk of sudden death.” New England Journal of Medicine 346, no. 15 (April 2002): 1113–18.
92 G. P. Amminger et al., “Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial.” Archives of General Psychiatry 67, no. 2 (February 2010): 146–54.
93 E. C. Rizos et al., “Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis.” JAMA 308, no. 10 (September 2012): 1024–33.
94 Q. Chen et al., “Effects of omega-3 fatty acid for sudden cardiac death prevention in patients with cardiovascular disease: a contemporary meta-analysis of randomized, controlled trials.” Cardiovascular Drugs and Therapy 25, no. 3 (June 2011): 259–65.
95 M. C. Morris et al., “Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease.” Archives of Neurology 60, no. 7 (July 2003): 940–46.
96 E. J. Schaefer et al., “Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study.” Archives of Neurology 63, no. 11 (November 2006): 1545–50.
97 P. Barberger-Gateau et al., “Dietary patterns and risk of dementia: the Three-City cohort study.” Neurology 69, no. 20 (November 2007): 1921–30.
98 H. M. Krumholz et al., “Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years.” JAMA 272, no. 17 (November 1994): 1335–40.
99 A. C. M. Jansen et al., “The contribution of classical risk factors to cardiovascular disease in familial hypercholesterolaemia: data in 2400 patients.” Journal of Internal Medicine 256, no. 6 (December 2004): 482–90.
100 R. Champeau, “Most heart attack patients’ cholesterol levels did not indicate cardiac risk.” newsroom.ucla.edu, January 12, 2009.
101 A. C. M. Jansen et al., “Genetic determinants of cardiovascular disease risk in familial hypercholesterolemia.” Arteriosclerosis, Thrombosis, and Vascular Biology 25, no. 7 (July 2005): 1475–81.
102 P. K. Elias et al., “Serum cholesterol and cognitive performance in the Framingham Heart Study.” Psychosomatic Medicine 67, no. 1 (January 2005): 24–30.
103 A. W. Weverling-Rijnsburger et al., “Total cholesterol and risk of mortality in the oldest old.” Lancet 350, no. 9085 (October 1997): 1119–23.
104 Y. Takata et al., “Serum total cholesterol concentration and 10-year mortality in an 85-year-old population.” Clinical Interventions in Aging 9 (January 2014): 293–300.
